Skip to main content
. Author manuscript; available in PMC: 2013 Jun 14.
Published in final edited form as: Lab Invest. 2010 Apr 19;90(6):812–823. doi: 10.1038/labinvest.2010.73

Table 4.

Subgroup Analysis: Fibrocyte Percentages, CD163 Expression, and Cytokine Levels (Older vs. Younger Controls)

<35 years (n=10) > 60 years (n=12) p-value
Fibrocyte percentage 0.620 ± 0.014 1.932 ± 0.3900 0.001
Fibrocyte concentration 0.070 ± 0.010 0.790 ± 0.265 0.007
Lymphocyte concentration 7.380 ± 0.680 18.31 ± 4.310 0.03
Monocyte concentration 1.661 ± 0.221 27.06 ± 1.312 0.0001
- LPS, percent CD163+ 2.465 ± 0.900 9.724 ± 3.744 0.02
+ LPS, percent CD163+ 3.632 ± 1.261 13.42 ± 2.766 0.01
IL-4 (pg/ml) 14.22 ± 2.99 62.47 ± 14.51 0.003
IL-10 (pg/ml) 4.169 ± 1.285 12.10 ± 1.88 0.004
IL-13 (pg/ml) 37.71 ± 13.27 121.2 ± 18.41 0.004
IL-1RA (pg/ml) 140.7 ± 48.76 118.6 ± 25.16 0.04
MCP-1 (pg/ml) 214.8 ± 34.59 322.5 ± 39.84 0.05
TNFα (pg/ml) 2.158 ± 0.76 2.591 ± 0.852 0.70
CCL-18 (pg/ml) 913.3 ± 33.92 1251 ± 102.1 0.01
M-CSF (pg/ml) 93.02 ± 51.60 324.5 ± 201.6 0.42
HHS Vulnerability Disclosure